It’s no secret that Boston, Massachusetts is home to many of the most groundbreaking advancements in medical discovery. That’s why yesterday, PhRMA sponsored its first national health care dialogue series focusing on the new era of medicine. The event, convened by The Atlantic, titled, “Through the Microscope: Examining Modern Medicine,” explored the transformation of patient care and the science that has revolutionized medical breakthroughs, new treatments and technologies, as well as the investments needed for future innovation.
Notable speakers included PhRMA president and CEO Stephen J. Ubl, biopharmaceutical research leaders Daniel Skovronsky of Eli Lilly and Company, Gilmore O’Neill of Biogen and Dana Farber Cancer Institute’s president and CEO Laurie Glimcher, MD.
Click here to watch the full video and learn more at GoBoldly.com
View Photos from The Event
Andrew Powaleny
Andrew Powaleny is the Deputy Vice President of Public Affairs at PhRMA, where he leads communications on scientific, regulatory and intellectual property issues, highlighting the biopharmaceutical industry’s efforts in developing innovative medicines and vaccines while promoting an environment that encourages necessary risk-taking. For five years starting in 2019, he launched and led PhRMA’s grassroots initiative, Voters for Cures, bringing patients and caregivers together to advocate for access to medicine and biopharmaceutical innovation. He also co-founded and co-chaired PRIDE Umbrella, a resource group for LGBTQ+ individuals. Prior to joining PhRMA in 2015, Andrew worked as a communications consultant in Washington, D.C., and as Deputy Press Secretary for the U.S. House Committee on Energy and Commerce under Chairman Fred Upton. He holds a degree in public policy and government from Eastern Connecticut State University, with a minor in music. Outside of work, Andrew enjoys exercise, musical theater and mentoring college students through The Fund for American Studies alumni association.
Andrew Powaleny
Bayh-Dole: The fuel for America’s innovation engine
ICYMI: Biopharmaceutical companies in America hit new investment milestone
World Sickle Cell Day: Recognizing the promise of gene therapy
America's cancer research progress is real and worth protecting
ICYMI: New era of medicine initiative kicks off in Boston
Patients
New Era of Medicine
Research and Development
ICYMI: New era of medicine initiative kicks off in Boston
ICYMI: New era of medicine initiative kicks off in Boston